Measuring antimicrobial susceptibility of Pseudomonas aeruginosa using Poloxamer 407 gel

Hiroyuki Yamada1, Naohito Koike, Tomoko Ehara

  • 1Department of Microbiology, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo, 160-8402, Japan.

Insights

Poloxamer 407 gel culture better mimics Pseudomonas aeruginosa biofilms than standard methods. This approach reveals increased antimicrobial resistance, aiding treatment selection for biofilm-related infections.

Area of Science:

  • Microbiology
  • Bacteriology
  • Antimicrobial Resistance

Background:

  • Pseudomonas aeruginosa causes opportunistic infections, often intractable due to antimicrobial resistance and biofilm formation.
  • Standard antimicrobial susceptibility testing (AST) methods do not fully account for biofilm's impact on resistance.
  • Biofilm formation is a critical factor in persistent bacterial infections.

Purpose of the Study:

  • To compare antimicrobial susceptibility of P. aeruginosa cultured in Poloxamer 407 gel versus Mueller-Hinton agar.
  • To evaluate Poloxamer 407 gel as a model for biofilm-related antimicrobial susceptibility testing.
  • To assess the influence of biofilm formation on P. aeruginosa resistance to beta-lactams.

Main Methods:

  • Utilized the Kirby-Bauer disk diffusion method for AST.
  • Cultured 24 strains of P. aeruginosa on Poloxamer 407 gel and Mueller-Hinton agar.
  • Employed scanning electron microscopy (SEM) to visualize biofilm formation and extracellular polymeric substance (EPS) production.

Main Results:

  • >60% of P. aeruginosa strains showed increased resistance to beta-lactams when cultured in Poloxamer 407 gel.
  • Typical biofilm formation and EPS production were observed only in bacteria cultured on Poloxamer 407 gel.
  • Significant differences in antimicrobial susceptibility were noted between the two culture mediums.

Conclusions:

  • Poloxamer 407 gel culture provides a more accurate model for P. aeruginosa biofilm-related AST.
  • This method may improve the selection of effective antimicrobial agents for biofilm-forming infections.
  • Standard AST methods may underestimate resistance in biofilm-forming pathogens like P. aeruginosa.